Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations
Clinical trial NCT05659914 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05659914
- Sponsor
- Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2025-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.